CV outcomes reduced by nonsteroidal MRA in patients with diabetes and CKD

3' education - Aug. 28, 2021 - Kevin Damman, MD, PhD - Groningen, The Netherlands

Educational information

This video was recorded during the digital ESC Congress 2021.

Faculty

Kevin Damman is clinical cardiologist and head of the heart transplant and left ventricular assist device program at the University Medical Center Groningen, The Netherlands.

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

Read our summary of the FIGARO trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.